News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|April 20, 2016

Monitoring Patients

Episodes in this series

EP. 1 Types of Multiple Myeloma

EP. 1 Types of Multiple Myeloma

EP. 2 Testing Procedures and Considerations

EP. 2 Testing Procedures and Considerations

EP. 3 Considerations For Treatment

EP. 3 Considerations For Treatment

EP. 4 Monitoring Patients

EP. 4 Monitoring Patients

EP. 5 Top Considerations for Maintenance Therapy

EP. 5 Top Considerations for Maintenance Therapy

EP. 6 New Drug Classes For Treatment

EP. 6 New Drug Classes For Treatment

EP. 7 Clinical Trials and Stem Cell Transplants

EP. 7 Clinical Trials and Stem Cell Transplants

EP. 8 Professional Expectations for Future

EP. 8 Professional Expectations for Future

Newsletter

Stay up to date on cancer updates, research and education

Related Content

The U.S. FDA has granted approval to Rybrevant Faspro, the first and only subcutaneous therapy for EGFR-mutated non-small cell lung cancer: © stock.adobe.com.

Rybrevant Faspro FDA-Approved as First Sub-Q Therapy for EGFR NSCLC

December 18th 2025

Dave Coulier, best known for his role in the sitcom “Full House,” recently sat down with CURE to discuss facing cancer for the second time.

‘Full House’ Star Dave Coulier Talks Tongue Cancer Diagnosis

December 17th 2025

The FDA has granted approval to treatment with Rubraca for some adult patients with previously-treated metastatic castration-resistant prostate cancer: © stock.adobe.com.

FDA Grants Regular Approval to Rubraca for Some With Prostate Cancer

December 17th 2025

At CURE, we strive to provide insight, education and inspiration for patients, survivors and caregivers at every stage of the cancer journey: © stock.adobe.com.

Education and Inspiration Across the Cancer Journey

ByMike Hennessy Jr.

December 17th 2025

Brian Sluga

Testicular Cancer Survivor Shares Story of Courage in New Book

December 17th 2025

Trending on CURE

Navigating the Holidays When Cancer Never Quite Leaves

‘Full House’ Star Dave Coulier Talks Tongue Cancer Diagnosis

FDA Grants Regular Approval to Rubraca for Some With Prostate Cancer

Padcev/Keytruda Combo Extends Survival in Muscle-Invasive Bladder Cancer

Rybrevant Faspro FDA-Approved as First Sub-Q Therapy for EGFR NSCLC